Paul Celano

Oncology
6535 N Charles St Ste 220
Towson, MD 21204

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4.

Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 06, 2026

Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.

Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 20, 2026

Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update.

Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 02, 2025

Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours.

Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours.

Journal: Clinical and translational medicine
Published: April 04, 2025

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.3.

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.3.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 22, 2023

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.3.

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.3.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 21, 2023

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2.

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 19, 2022

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2.

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 19, 2022

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline.

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 11, 2022

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline.

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 11, 2022

Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.

Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 11, 2020

ASCO Standards for Safe Handling of Hazardous Drugs.

ASCO Standards for Safe Handling of Hazardous Drugs.

Journal: Journal of oncology practice
Published: January 23, 2019
Showing 1-12 of 22

Last Updated: 09/26/2026